Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9334331 Bispecific antibodies

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
November 17, 2011
Date of Patent
May 10, 2016
Patent Application Number
13885421
Patent Citations Received
‌
US Patent 12133867 Universal anti-CD22 chimeric antigen receptor engineered immune cells
0
‌
US Patent 12122840 Method of modifying isoelectric point of antibody via amino acid substitution in CDR
0
‌
US Patent 12129297 Antibodies against TIM3 and uses thereof
0
‌
US Patent 12129300 Antibody variable domains targeting the NKG2D receptor
0
‌
US Patent 11667709 Anti-TIGIT antibodies and methods of use
0
‌
US Patent 11680101 Anti-OPG antibodies
0
‌
US Patent 11753469 Methods of using bispecific CD33 and CD3 binding proteins
‌
US Patent 11760795 Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses thereof for treating cancer cachexia and cancer
‌
US Patent 11771743 Methods for preventing or treating allergy by administering an IL-4R antagonist
‌
US Patent 11780923 PD-L1 antibody, antigen-binding fragment thereof and medical application thereof
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9334331
Patent Primary Examiner
‌
Michael Szperka

Find more entities like US Patent 9334331 Bispecific antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.